PARK7 and Parkinson disease: Similar to our current model, Inden and coworkers induced Parkinson’s disease with a unilateral 6-OHDA injection into the s.n. A co-injection with a recombinant PARK7 protein protected against the loss of TH-immunoreactive cells and the drug-induced rotational asymmetry [90].